| Companies sponsors |
Merck (avelumab) |
| Others |
Department of Health and Social Care |
| |
NHS England |
| Patient carer groups |
Action Kidney Cancer |
| |
Kidney Cancer UK |
| |
Kidney Research UK |
| Professional groups |
Association of Cancer Physicians |
| |
British Uro-oncology Group |
| |
Cancer Research UK |
| |
Royal College of Physicians |
| |
Royal College of Radiologists |
| Associated public health groups |
None |
| Comparator companies |
Bristol Myers Squibb Pharmaceuticals (ipilimumab, nivolumab) (confidentiality agreement signed, participating) |
| |
Eisai (lenvatinib) (confidentiality agreement signed, participating) |
| |
Merck Sharp & Dohme (UK) (pembrolizumab) (confidentiality agreement signed, participating) |
| |
Pfizer (sunitinib) (confidentiality agreement signed, participating) |
| |
Accord-UK (sunitinib) (confidentiality agreement not signed, not participating) |
| |
Dr Reddy’s Laboratories (sunitinib) (confidentiality agreement not signed, not participating) |
| |
Eusa Pharma (tivozanib) (confidentiality agreement not signed, not participating) |
| |
Ipsen (cabozantinib) (confidentiality agreement not signed, not participating) |
| |
MSN laboratories (sunitinib) (confidentiality agreement not signed, not participating) |
| |
Novartis (pazopanib) (confidentiality agreement not signed, not participating) |
| |
Piramal Critical Care (sunitinib) (confidentiality agreement not signed, not participating) |
| |
Sandoz (sunitinib) (confidentiality agreement not signed, not participating) |
| |
Teva UK (sunitinib) (confidentiality agreement not signed, not participating) |
| |
Viatris UK Healthcare (sunitinib) (confidentiality agreement not signed, not participating) |
| |
Zentiva (sunitinib) (confidentiality agreement not signed, not participating) |
| General commentators |
All Wales Therapeutics and Toxicology Centre |
| |
British National Formulary |
| |
Department of Health, Social Services and Public Safety for Northern Ireland |
| |
Healthcare Improvement Scotland |
| |
Medicines and Healthcare products Regulatory Agency |
| |
Scottish Medicines Consortium |
| |
Welsh Government |
| |
Welsh Health Specialised Services Committee |
| Relevant research groups |
Institute of Cancer Research |